Aerovate Therapeutics Inc. (AVTE) NASDAQ
$13.42 0.08 (0.60%)
Market Cap: $368.85M
As of 10/04/23 04:00 PM EDT. Market closed.
Aerovate Therapeutics Inc. (AVTE)
NASDAQ
$13.42
0.08 (0.60%)
Market Cap: $368.85M
As of 10/04/23 04:00 PM EDT. Market closed.
aerovate is a clinical stage biopharmaceutical company focused on developing drugs that meaningfully improve the lives of patients with rare cardiopulmonary disease. aerovate's initial focus is on advancing av-101, its dry powder inhaled formulation of the drug imatinib for the treatment of pulmonary arterial hypertension, or ... read more
aerovate is a clinical stage biopharmaceutical company focused on developing drugs that meaningfully improve the lives of patients with rare cardiopulmonary disease. aerovate's initial focus is on advancing av-101, its dry powder inhaled formulation of the drug imatinib for the treatment of pulmonary arterial hypertension, or pah. read less
COMPANY PROFILE
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology
Full Time Employees
5
Address
.
PRICE CHART FOR AEROVATE THERAPEUTICS INC
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$13.36
Previous Close
$13.34
Days Range
$13.05 - $13.69
52 week range
$12.29 - $30.79
Volume
36,665
Avg. Volume (30 days)
77,523
Market Cap
$368.85M
Dividend Yield
-
P/E
-
Shares Outstanding
27,650,000
Open
$13.36
Previous Close
$13.34
Days Range
$13.05 - $13.69
52 week range
$12.29 - $30.79
Volume
36,665
Avg. Volume (30 days)
77,523
Market Cap
$368.85M
Dividend Yield
-
P/E
-
Shares Outstanding
27,650,000
FINANCIAL STATEMENTS FOR AEROVATE THERAPEUTICS INC
LOADING...
Open in: 
Open in:
INSIDER TRANSACTIONS FOR AEROVATE THERAPEUTICS INC
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| Dake Benjamin T | SEE REMARKS | Sep 07, 2023 | Option Exercise | $2.14 | 30 | 64 | 1,321 | Sep 08, 2023, 06:00 PM |
| Dake Benjamin T | SEE REMARKS | Sep 06, 2023 | Option Exercise | $1.89 | 3,931 | 7,447 | 5,222 | Sep 08, 2023, 06:00 PM |
| Dake Benjamin T | SEE REMARKS | Sep 07, 2023 | Sale | $15.01 | 30 | 450 | 1,291 | Sep 08, 2023, 06:00 PM |
| Dake Benjamin T | SEE REMARKS | Sep 06, 2023 | Sale | $15.06 | 3,931 | 59,187 | 1,291 | Sep 08, 2023, 06:00 PM |
| Dake Benjamin T | SEE REMARKS | Aug 07, 2023 | Option Exercise | $2.05 | 10,283 | 21,041 | 11,574 | Aug 09, 2023, 06:00 PM |
| Dake Benjamin T | SEE REMARKS | Aug 07, 2023 | Sale | $15.52 | 10,283 | 159,580 | 1,832 | Aug 09, 2023, 06:00 PM |
| NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | Jul 28, 2023 | Option Exercise | $2.14 | 5,478 | 11,723 | 5,478 | Aug 01, 2023, 06:00 PM |
| NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | Jul 28, 2023 | Sale | $18.00 | 5,478 | 98,604 | 0 | Aug 01, 2023, 06:00 PM |
| NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | Jul 17, 2023 | Option Exercise | $2.14 | 4,522 | 9,677 | 4,522 | Jul 19, 2023, 06:00 PM |
| NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | Jul 17, 2023 | Sale | $18.11 | 4,522 | 81,896 | 0 | Jul 19, 2023, 06:00 PM |
| Dake Benjamin T | SEE REMARKS | Jul 06, 2023 | Option Exercise | $2.05 | 10,283 | 21,041 | 11,574 | Jul 07, 2023, 06:00 PM |
| Dake Benjamin T | SEE REMARKS | Jul 06, 2023 | Sale | $16.66 | 10,283 | 171,284 | 1,291 | Jul 07, 2023, 06:00 PM |
| NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | Jul 05, 2023 | Option Exercise | $2.02 | 2,250 | 4,555 | 3,859 | Jul 07, 2023, 06:00 PM |
| NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | Jul 05, 2023 | Sale | $17.30 | 2,250 | 38,915 | 1,828 | Jul 07, 2023, 06:00 PM |
| NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | Jul 03, 2023 | Option Exercise | $2.14 | 10,000 | 21,400 | 10,000 | Jul 05, 2023, 06:00 PM |
| NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | Jul 03, 2023 | Sale | $18.00 | 10,000 | 180,000 | 0 | Jul 05, 2023, 06:00 PM |
| Dake Benjamin T | SEE REMARKS | Jun 06, 2023 | Option Exercise | $2.05 | 10,283 | 21,041 | 11,574 | Jun 08, 2023, 06:00 PM |
| Dake Benjamin T | SEE REMARKS | Jun 06, 2023 | Sale | $16.28 | 10,283 | 167,416 | 1,306 | Jun 08, 2023, 06:00 PM |
| NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | Jun 05, 2023 | Option Exercise | $2.02 | 2,250 | 4,555 | 3,859 | Jun 07, 2023, 06:00 PM |
| NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | Jun 05, 2023 | Sale | $16.26 | 2,250 | 36,576 | 1,609 | Jun 07, 2023, 06:00 PM |
| Gillies Hunter | CHIEF MEDICAL OFFICER | May 19, 2023 | Option Exercise | $1.74 | 65 | 113 | 3,316 | May 23, 2023, 06:00 PM |
| Gillies Hunter | CHIEF MEDICAL OFFICER | May 19, 2023 | Sale | $19.50 | 65 | 1,268 | 3,251 | May 23, 2023, 06:00 PM |
| Gillies Hunter | CHIEF MEDICAL OFFICER | May 17, 2023 | Option Exercise | $1.74 | 1,090 | 1,897 | 4,341 | May 19, 2023, 06:00 PM |
| Gillies Hunter | CHIEF MEDICAL OFFICER | May 17, 2023 | Sale | $19.59 | 1,090 | 21,356 | 3,251 | May 19, 2023, 06:00 PM |
| NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | May 05, 2023 | Option Exercise | $2.02 | 2,250 | 4,555 | 3,859 | May 09, 2023, 06:00 PM |
| NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | May 05, 2023 | Sale | $20.87 | 2,250 | 46,957 | 1,814 | May 09, 2023, 06:00 PM |
| Dake Benjamin T | SEE REMARKS | May 08, 2023 | Option Exercise | $2.05 | 10,284 | 21,043 | 11,575 | May 09, 2023, 06:00 PM |
| Dake Benjamin T | SEE REMARKS | May 08, 2023 | Sale | $21.80 | 10,284 | 224,160 | 2,890 | May 09, 2023, 06:00 PM |
| Verwijs Marinus | SENIOR VICE PRESIDENT, CMC | May 03, 2023 | Sale | $20.79 | 759 | 15,779 | 0 | May 05, 2023, 06:00 PM |
| NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | May 01, 2023 | Option Exercise | $2.14 | 15,000 | 32,100 | 15,693 | May 03, 2023, 06:00 PM |
| NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | May 01, 2023 | Sale | $20.61 | 15,000 | 309,088 | 693 | May 03, 2023, 06:00 PM |
| NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | May 02, 2023 | Sale | $21.15 | 693 | 14,657 | 0 | May 03, 2023, 06:00 PM |
| Gillies Hunter | CHIEF MEDICAL OFFICER | Apr 21, 2023 | Option Exercise | $1.74 | 4,000 | 6,960 | 5,960 | Apr 25, 2023, 06:00 PM |
| Gillies Hunter | CHIEF MEDICAL OFFICER | Apr 21, 2023 | Sale | $19.50 | 4,000 | 78,000 | 1,960 | Apr 25, 2023, 06:00 PM |
| Dake Benjamin T | SEE REMARKS | Apr 06, 2023 | Option Exercise | $2.05 | 10,283 | 21,041 | 10,283 | Apr 07, 2023, 06:00 PM |
| Dake Benjamin T | SEE REMARKS | Apr 06, 2023 | Sale | $18.17 | 10,283 | 186,829 | 0 | Apr 07, 2023, 06:00 PM |
| NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | Apr 05, 2023 | Option Exercise | $2.02 | 2,250 | 4,555 | 3,859 | Apr 07, 2023, 06:00 PM |
| NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | Apr 05, 2023 | Sale | $18.20 | 2,250 | 40,942 | 2,144 | Apr 07, 2023, 06:00 PM |
| NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | Apr 03, 2023 | Option Exercise | $2.14 | 15,000 | 32,100 | 15,000 | Apr 05, 2023, 06:00 PM |
| NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | Apr 03, 2023 | Sale | $19.39 | 15,000 | 290,916 | 5,828 | Apr 05, 2023, 06:00 PM |
| Dake Benjamin T | SEE REMARKS | Mar 06, 2023 | Option Exercise | $2.05 | 10,282 | 21,039 | 10,282 | Mar 08, 2023, 06:00 PM |
| Dake Benjamin T | SEE REMARKS | Mar 06, 2023 | Sale | $23.73 | 10,282 | 243,954 | 215 | Mar 08, 2023, 06:00 PM |
| NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | Mar 06, 2023 | Option Exercise | $2.02 | 2,250 | 4,555 | 3,859 | Mar 08, 2023, 06:00 PM |
| NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | Mar 06, 2023 | Sale | $23.75 | 2,250 | 53,440 | 1,654 | Mar 08, 2023, 06:00 PM |
| NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | Mar 01, 2023 | Option Exercise | $2.14 | 15,000 | 32,100 | 15,000 | Mar 03, 2023, 06:00 PM |
| NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | Mar 01, 2023 | Sale | $23.81 | 15,000 | 357,196 | 9,038 | Mar 03, 2023, 06:00 PM |
| Dake Benjamin T | SEE REMARKS | Feb 06, 2023 | Option Exercise | $2.05 | 10,284 | 21,043 | 10,284 | Feb 08, 2023, 06:00 PM |
| Dake Benjamin T | SEE REMARKS | Feb 06, 2023 | Sale | $24.59 | 10,284 | 252,881 | 1,426 | Feb 08, 2023, 06:00 PM |
| NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | Feb 06, 2023 | Option Exercise | $2.02 | 2,250 | 4,555 | 3,859 | Feb 08, 2023, 06:00 PM |
| NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | Feb 06, 2023 | Sale | $24.27 | 2,250 | 54,612 | 1,609 | Feb 08, 2023, 06:00 PM |
| NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | Feb 01, 2023 | Option Exercise | $2.14 | 15,000 | 32,100 | 15,000 | Feb 03, 2023, 06:00 PM |
| NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | Feb 01, 2023 | Sale | $22.68 | 15,000 | 340,197 | 4,495 | Feb 03, 2023, 06:00 PM |
| Dake Benjamin T | SEE REMARKS | Jan 06, 2023 | Option Exercise | $2.05 | 10,284 | 21,043 | 10,284 | Jan 09, 2023, 06:00 PM |
| Dake Benjamin T | SEE REMARKS | Jan 06, 2023 | Sale | $25.98 | 10,284 | 267,203 | 2,792 | Jan 09, 2023, 06:00 PM |
| NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | Jan 05, 2023 | Option Exercise | $2.02 | 2,250 | 4,555 | 3,859 | Jan 09, 2023, 06:00 PM |
| NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | Jan 05, 2023 | Sale | $26.40 | 2,250 | 59,405 | 1,609 | Jan 09, 2023, 06:00 PM |
| NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | Jan 03, 2023 | Option Exercise | $2.14 | 15,000 | 32,100 | 15,000 | Jan 05, 2023, 05:00 PM |
| NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | Jan 03, 2023 | Sale | $27.07 | 15,000 | 406,076 | 3,073 | Jan 05, 2023, 05:00 PM |
| Dake Benjamin T | SEE REMARKS | Dec 12, 2022 | Option Exercise | $2.14 | 2,059 | 4,406 | 2,059 | Dec 14, 2022, 06:00 PM |
| Dake Benjamin T | SEE REMARKS | Dec 12, 2022 | Sale | $29.43 | 2,059 | 60,591 | 2,039 | Dec 14, 2022, 06:00 PM |
| Eldridge George A | SEE REMARKS | Dec 09, 2022 | Option Exercise | $2.14 | 3,969 | 8,494 | 5,929 | Dec 13, 2022, 06:00 PM |
| Eldridge George A | SEE REMARKS | Dec 12, 2022 | Option Exercise | $2.14 | 10,000 | 21,400 | 11,960 | Dec 13, 2022, 06:00 PM |
| Eldridge George A | SEE REMARKS | Dec 09, 2022 | Sale | $24.38 | 3,969 | 96,765 | 2,543 | Dec 13, 2022, 06:00 PM |
| Eldridge George A | SEE REMARKS | Dec 12, 2022 | Sale | $30.04 | 10,000 | 300,428 | 1,960 | Dec 13, 2022, 06:00 PM |
| Dake Benjamin T | SEE REMARKS | Dec 09, 2022 | Option Exercise | $2.14 | 394 | 843 | 394 | Dec 12, 2022, 06:00 PM |
| Dake Benjamin T | SEE REMARKS | Dec 08, 2022 | Option Exercise | $2.14 | 10,000 | 21,400 | 10,000 | Dec 12, 2022, 06:00 PM |
| Dake Benjamin T | SEE REMARKS | Dec 09, 2022 | Sale | $25.03 | 394 | 9,861 | 0 | Dec 12, 2022, 06:00 PM |
| Dake Benjamin T | SEE REMARKS | Dec 08, 2022 | Sale | $22.64 | 10,000 | 226,449 | 9,072 | Dec 12, 2022, 06:00 PM |
| Eldridge George A | SEE REMARKS | Dec 08, 2022 | Option Exercise | $2.14 | 12,011 | 25,704 | 13,971 | Dec 09, 2022, 06:00 PM |
| Eldridge George A | SEE REMARKS | Dec 07, 2022 | Option Exercise | $2.14 | 11,637 | 24,903 | 13,597 | Dec 09, 2022, 06:00 PM |
| Eldridge George A | SEE REMARKS | Dec 08, 2022 | Sale | $23.87 | 12,011 | 286,700 | 13,011 | Dec 09, 2022, 06:00 PM |
| Eldridge George A | SEE REMARKS | Dec 07, 2022 | Sale | $19.77 | 11,637 | 230,083 | 6,518 | Dec 09, 2022, 06:00 PM |
| Dake Benjamin T | SEE REMARKS | Dec 06, 2022 | Option Exercise | $2.12 | 40,000 | 84,635 | 40,000 | Dec 08, 2022, 06:00 PM |
| Dake Benjamin T | SEE REMARKS | Dec 06, 2022 | Sale | $17.67 | 40,000 | 706,772 | 37,989 | Dec 08, 2022, 06:00 PM |
| NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | Dec 05, 2022 | Option Exercise | $2.02 | 2,250 | 4,555 | 3,859 | Dec 07, 2022, 06:00 PM |
| NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | Dec 05, 2022 | Sale | $17.38 | 2,250 | 39,114 | 1,609 | Dec 07, 2022, 06:00 PM |
| NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | Dec 01, 2022 | Option Exercise | $2.14 | 15,000 | 32,100 | 15,000 | Dec 02, 2022, 07:00 PM |
| NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | Dec 01, 2022 | Sale | $18.00 | 15,000 | 270,000 | 0 | Dec 02, 2022, 07:00 PM |
| Eldridge George A | SEE REMARKS | Nov 30, 2022 | Option Exercise | $2.14 | 85 | 182 | 2,045 | Dec 02, 2022, 07:00 PM |
| Eldridge George A | SEE REMARKS | Nov 30, 2022 | Sale | $19.06 | 85 | 1,620 | 1,960 | Dec 02, 2022, 07:00 PM |
| Eldridge George A | SEE REMARKS | Nov 23, 2022 | Option Exercise | $2.14 | 1,261 | 2,699 | 3,221 | Nov 28, 2022, 05:00 PM |
| Eldridge George A | SEE REMARKS | Nov 23, 2022 | Sale | $19.07 | 1,261 | 24,048 | 1,960 | Nov 28, 2022, 05:00 PM |
| Eldridge George A | SEE REMARKS | Nov 22, 2022 | Option Exercise | $2.14 | 174 | 372 | 2,134 | Nov 22, 2022, 08:00 PM |
| Eldridge George A | SEE REMARKS | Nov 21, 2022 | Option Exercise | $2.14 | 2 | 4 | 1,962 | Nov 22, 2022, 08:00 PM |
| Eldridge George A | SEE REMARKS | Nov 18, 2022 | Option Exercise | $2.14 | 861 | 1,843 | 2,821 | Nov 22, 2022, 08:00 PM |
| Eldridge George A | SEE REMARKS | Nov 22, 2022 | Sale | $19.01 | 174 | 3,308 | 1,960 | Nov 22, 2022, 08:00 PM |
| Eldridge George A | SEE REMARKS | Nov 21, 2022 | Sale | $19.00 | 2 | 38 | 1,960 | Nov 22, 2022, 08:00 PM |
| Eldridge George A | SEE REMARKS | Nov 18, 2022 | Sale | $19.52 | 861 | 16,805 | 2,041 | Nov 22, 2022, 08:00 PM |
| Dake Benjamin T | SEE REMARKS | Nov 11, 2022 | Option Exercise | $2.14 | 6,198 | 13,264 | 6,198 | Nov 14, 2022, 05:00 PM |
| Dake Benjamin T | SEE REMARKS | Nov 10, 2022 | Option Exercise | $2.14 | 1,800 | 3,852 | 1,800 | Nov 14, 2022, 05:00 PM |
| Dake Benjamin T | SEE REMARKS | Nov 09, 2022 | Option Exercise | $2.14 | 14,000 | 29,960 | 14,000 | Nov 14, 2022, 05:00 PM |
| Dake Benjamin T | SEE REMARKS | Nov 11, 2022 | Sale | $20.69 | 6,198 | 128,236 | 1,746 | Nov 14, 2022, 05:00 PM |
| Dake Benjamin T | SEE REMARKS | Nov 10, 2022 | Sale | $20.10 | 1,800 | 36,172 | 0 | Nov 14, 2022, 05:00 PM |
| Dake Benjamin T | SEE REMARKS | Nov 09, 2022 | Sale | $17.91 | 14,000 | 250,677 | 0 | Nov 14, 2022, 05:00 PM |
| Dake Benjamin T | SEE REMARKS | Nov 08, 2022 | Option Exercise | $2.14 | 8,373 | 17,918 | 8,373 | Nov 09, 2022, 05:00 PM |
| Dake Benjamin T | SEE REMARKS | Nov 07, 2022 | Option Exercise | $2.09 | 17,627 | 36,757 | 17,627 | Nov 09, 2022, 05:00 PM |
| Dake Benjamin T | SEE REMARKS | Nov 08, 2022 | Sale | $18.09 | 8,373 | 151,458 | 0 | Nov 09, 2022, 05:00 PM |
| Dake Benjamin T | SEE REMARKS | Nov 07, 2022 | Sale | $18.32 | 17,627 | 322,894 | 6,505 | Nov 09, 2022, 05:00 PM |
| NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | Nov 07, 2022 | Option Exercise | $2.02 | 2,250 | 4,555 | 3,859 | Nov 09, 2022, 05:00 PM |
| NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | Nov 07, 2022 | Sale | $19.20 | 2,250 | 43,194 | 3,409 | Nov 09, 2022, 05:00 PM |
| NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | Nov 01, 2022 | Sale | $19.50 | 1,038 | 20,241 | 0 | Nov 03, 2022, 05:00 PM |
| Verwijs Marinus | SENIOR VICE PRESIDENT, CMC | Nov 02, 2022 | Sale | $18.89 | 1,130 | 21,346 | 0 | Nov 03, 2022, 05:00 PM |
| Dake Benjamin T | SEE REMARKS | Oct 18, 2022 | Option Exercise | $2.14 | 5,705 | 12,209 | 5,705 | Oct 20, 2022, 05:00 PM |
| Dake Benjamin T | SEE REMARKS | Oct 18, 2022 | Sale | $21.08 | 5,705 | 120,287 | 0 | Oct 20, 2022, 05:00 PM |
| Dake Benjamin T | SEE REMARKS | Oct 14, 2022 | Option Exercise | $2.14 | 110 | 235 | 110 | Oct 18, 2022, 05:01 PM |
| Dake Benjamin T | SEE REMARKS | Oct 17, 2022 | Option Exercise | $2.14 | 4,185 | 8,956 | 4,185 | Oct 18, 2022, 05:01 PM |
| Dake Benjamin T | SEE REMARKS | Oct 17, 2022 | Sale | $20.16 | 4,185 | 84,380 | 0 | Oct 18, 2022, 05:01 PM |
| Dake Benjamin T | SEE REMARKS | Oct 14, 2022 | Sale | $20.05 | 110 | 2,205 | 0 | Oct 18, 2022, 05:01 PM |
| Dake Benjamin T | SEE REMARKS | Oct 10, 2022 | Option Exercise | $2.14 | 4,954 | 10,602 | 4,954 | Oct 12, 2022, 05:00 PM |
| Dake Benjamin T | SEE REMARKS | Oct 10, 2022 | Sale | $16.89 | 4,954 | 83,681 | 1,430 | Oct 12, 2022, 05:00 PM |
| Dake Benjamin T | SEE REMARKS | Oct 06, 2022 | Option Exercise | $2.07 | 13,040 | 26,941 | 13,040 | Oct 11, 2022, 05:00 PM |
| Dake Benjamin T | SEE REMARKS | Oct 07, 2022 | Option Exercise | $2.14 | 10,520 | 22,513 | 10,520 | Oct 11, 2022, 05:00 PM |
| Dake Benjamin T | SEE REMARKS | Oct 07, 2022 | Sale | $16.01 | 10,520 | 168,460 | 1,757 | Oct 11, 2022, 05:00 PM |
| Dake Benjamin T | SEE REMARKS | Oct 06, 2022 | Sale | $15.82 | 13,040 | 206,344 | 1,830 | Oct 11, 2022, 05:00 PM |
| NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | Oct 05, 2022 | Option Exercise | $2.02 | 2,250 | 4,555 | 3,859 | Oct 07, 2022, 05:00 PM |
| NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | Oct 05, 2022 | Sale | $15.75 | 2,250 | 35,447 | 1,800 | Oct 07, 2022, 05:00 PM |
| Dake Benjamin T | SEE REMARKS | Sep 12, 2022 | Option Exercise | $2.14 | 7,520 | 16,093 | 7,520 | Sep 14, 2022, 05:15 PM |
| Dake Benjamin T | SEE REMARKS | Sep 12, 2022 | Sale | $17.33 | 7,520 | 130,307 | 2,248 | Sep 14, 2022, 05:15 PM |
| Dake Benjamin T | See Remarks | Sep 08, 2022 | Option Exercise | $1.74 | 3,120 | 5,429 | 3,120 | Sep 12, 2022, 05:30 PM |
| Dake Benjamin T | See Remarks | Sep 09, 2022 | Option Exercise | $2.12 | 4,720 | 9,998 | 4,720 | Sep 12, 2022, 05:30 PM |
| Dake Benjamin T | See Remarks | Sep 08, 2022 | Sale | $18.20 | 3,120 | 56,782 | 629 | Sep 12, 2022, 05:30 PM |
| Dake Benjamin T | See Remarks | Sep 09, 2022 | Sale | $17.54 | 4,720 | 82,803 | 176 | Sep 12, 2022, 05:30 PM |
| Dake Benjamin T | See Remarks | Sep 07, 2022 | Option Exercise | $1.74 | 8,220 | 14,303 | 8,220 | Sep 08, 2022, 05:30 PM |
| Dake Benjamin T | See Remarks | Sep 06, 2022 | Option Exercise | $1.74 | 9,166 | 15,949 | 9,166 | Sep 08, 2022, 05:30 PM |
| Dake Benjamin T | See Remarks | Sep 07, 2022 | Sale | $18.42 | 3,663 | 67,477 | 3,658 | Sep 08, 2022, 05:30 PM |
| Dake Benjamin T | See Remarks | Sep 06, 2022 | Sale | $18.53 | 9,166 | 169,876 | 4,744 | Sep 08, 2022, 05:30 PM |
| NIVEN RALPH | Chief Scientific Officer | Sep 06, 2022 | Option Exercise | $2.02 | 2,250 | 4,555 | 3,859 | Sep 07, 2022, 05:30 PM |
| NIVEN RALPH | Chief Scientific Officer | Sep 06, 2022 | Sale | $19.00 | 2,250 | 42,750 | 1,609 | Sep 07, 2022, 05:30 PM |
| NIVEN RALPH | Chief Scientific Officer | Aug 18, 2022 | Option Exercise | $2.02 | 2,250 | 4,555 | 3,859 | Aug 19, 2022, 05:00 PM |
| NIVEN RALPH | Chief Scientific Officer | Aug 18, 2022 | Sale | $21.18 | 2,250 | 47,657 | 1,609 | Aug 19, 2022, 05:00 PM |
| Dake Benjamin T | See Remarks | Aug 16, 2022 | Option Exercise | $1.74 | 21,000 | 36,540 | 21,000 | Aug 18, 2022, 05:00 PM |
| Dake Benjamin T | See Remarks | Aug 16, 2022 | Sale | $23.00 | 21,000 | 482,932 | 10,525 | Aug 18, 2022, 05:00 PM |
| Dake Benjamin T | See Remarks | Aug 11, 2022 | Option Exercise | $1.74 | 1,347 | 2,344 | 1,347 | Aug 12, 2022, 05:15 PM |
| Dake Benjamin T | See Remarks | Aug 10, 2022 | Option Exercise | $1.74 | 12,720 | 22,133 | 12,720 | Aug 12, 2022, 05:15 PM |
| Dake Benjamin T | See Remarks | Aug 11, 2022 | Sale | $23.93 | 1,347 | 32,232 | 79 | Aug 12, 2022, 05:15 PM |
| Dake Benjamin T | See Remarks | Aug 10, 2022 | Sale | $24.09 | 12,720 | 306,366 | 780 | Aug 12, 2022, 05:15 PM |
| Dake Benjamin T | See Remarks | Aug 08, 2022 | Option Exercise | $1.74 | 6,943 | 12,081 | 6,943 | Aug 10, 2022, 05:15 PM |
| Dake Benjamin T | See Remarks | Aug 09, 2022 | Option Exercise | $1.74 | 8,700 | 15,138 | 8,700 | Aug 10, 2022, 05:15 PM |
| Dake Benjamin T | See Remarks | Aug 09, 2022 | Sale | $24.06 | 8,700 | 209,325 | 2,791 | Aug 10, 2022, 05:15 PM |
| Dake Benjamin T | See Remarks | Aug 08, 2022 | Sale | $24.62 | 6,943 | 170,962 | 2,954 | Aug 10, 2022, 05:15 PM |
| Cormorant Asset Management, LP | Former 10% Owner | Jul 02, 2021 | Buy | $14.00 | 500,000 | 7,000,000 | 2,030,691 | Jul 07, 2021, 04:45 PM |
| RA CAPITAL MANAGEMENT, L.P. | Director | Jul 02, 2021 | Buy | $14.00 | 2,785,714 | 38,999,996 | 6,965,568 | Jul 06, 2021, 05:03 PM |
| Sofinnova Venture Partners X, L.P. | 10% Owner | Jul 02, 2021 | Buy | $14.00 | 357,142 | 4,999,988 | 3,758,686 | Jul 06, 2021, 04:28 PM |
| Katabi Maha | Director | Jul 02, 2021 | Buy | $14.00 | 357,142 | 4,999,988 | 3,758,686 | Jul 06, 2021, 04:27 PM |
| GRAYZEL DAVID S. | Director | Jul 02, 2021 | Buy | $14.00 | 535,714 | 7,499,996 | 3,103,879 | Jul 06, 2021, 04:27 PM |
| Atlas Venture Fund XII, L.P. | 10% Owner | Jul 02, 2021 | Buy | $14.00 | 535,714 | 7,499,996 | 3,103,879 | Jul 06, 2021, 04:26 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
| Owner | Relationship | Date | Value($) |
| Dake Benjamin T | SEE REMARKS | 09/07/2023 | 64 |
| Dake Benjamin T | SEE REMARKS | 09/06/2023 | 7,447 |
| Dake Benjamin T | SEE REMARKS | 09/07/2023 | 450 |
| Dake Benjamin T | SEE REMARKS | 09/06/2023 | 59,187 |
| Dake Benjamin T | SEE REMARKS | 08/07/2023 | 21,041 |
| Dake Benjamin T | SEE REMARKS | 08/07/2023 | 159,580 |
| NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | 07/28/2023 | 11,723 |
| NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | 07/28/2023 | 98,604 |
| NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | 07/17/2023 | 9,677 |
| NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | 07/17/2023 | 81,896 |
| Dake Benjamin T | SEE REMARKS | 07/06/2023 | 21,041 |
| Dake Benjamin T | SEE REMARKS | 07/06/2023 | 171,284 |
| NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | 07/05/2023 | 4,555 |
| NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | 07/05/2023 | 38,915 |
| NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | 07/03/2023 | 21,400 |
| NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | 07/03/2023 | 180,000 |
| Dake Benjamin T | SEE REMARKS | 06/06/2023 | 21,041 |
| Dake Benjamin T | SEE REMARKS | 06/06/2023 | 167,416 |
| NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | 06/05/2023 | 4,555 |
| NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | 06/05/2023 | 36,576 |
| Gillies Hunter | CHIEF MEDICAL OFFICER | 05/19/2023 | 113 |
| Gillies Hunter | CHIEF MEDICAL OFFICER | 05/19/2023 | 1,268 |
| Gillies Hunter | CHIEF MEDICAL OFFICER | 05/17/2023 | 1,897 |
| Gillies Hunter | CHIEF MEDICAL OFFICER | 05/17/2023 | 21,356 |
| NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | 05/05/2023 | 4,555 |
| NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | 05/05/2023 | 46,957 |
| Dake Benjamin T | SEE REMARKS | 05/08/2023 | 21,043 |
| Dake Benjamin T | SEE REMARKS | 05/08/2023 | 224,160 |
| Verwijs Marinus | SENIOR VICE PRESIDENT, CMC | 05/03/2023 | 15,779 |
| NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | 05/01/2023 | 32,100 |
| NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | 05/01/2023 | 309,088 |
| NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | 05/02/2023 | 14,657 |
| Gillies Hunter | CHIEF MEDICAL OFFICER | 04/21/2023 | 6,960 |
| Gillies Hunter | CHIEF MEDICAL OFFICER | 04/21/2023 | 78,000 |
| Dake Benjamin T | SEE REMARKS | 04/06/2023 | 21,041 |
| Dake Benjamin T | SEE REMARKS | 04/06/2023 | 186,829 |
| NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | 04/05/2023 | 4,555 |
| NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | 04/05/2023 | 40,942 |
| NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | 04/03/2023 | 32,100 |
| NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | 04/03/2023 | 290,916 |
| Dake Benjamin T | SEE REMARKS | 03/06/2023 | 21,039 |
| Dake Benjamin T | SEE REMARKS | 03/06/2023 | 243,954 |
| NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | 03/06/2023 | 4,555 |
| NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | 03/06/2023 | 53,440 |
| NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | 03/01/2023 | 32,100 |
| NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | 03/01/2023 | 357,196 |
| Dake Benjamin T | SEE REMARKS | 02/06/2023 | 21,043 |
| Dake Benjamin T | SEE REMARKS | 02/06/2023 | 252,881 |
| NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | 02/06/2023 | 4,555 |
| NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | 02/06/2023 | 54,612 |
| NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | 02/01/2023 | 32,100 |
| NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | 02/01/2023 | 340,197 |
| Dake Benjamin T | SEE REMARKS | 01/06/2023 | 21,043 |
| Dake Benjamin T | SEE REMARKS | 01/06/2023 | 267,203 |
| NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | 01/05/2023 | 4,555 |
| NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | 01/05/2023 | 59,405 |
| NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | 01/03/2023 | 32,100 |
| NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | 01/03/2023 | 406,076 |
| Dake Benjamin T | SEE REMARKS | 12/12/2022 | 4,406 |
| Dake Benjamin T | SEE REMARKS | 12/12/2022 | 60,591 |
| Eldridge George A | SEE REMARKS | 12/09/2022 | 8,494 |
| Eldridge George A | SEE REMARKS | 12/12/2022 | 21,400 |
| Eldridge George A | SEE REMARKS | 12/09/2022 | 96,765 |
| Eldridge George A | SEE REMARKS | 12/12/2022 | 300,428 |
| Dake Benjamin T | SEE REMARKS | 12/09/2022 | 843 |
| Dake Benjamin T | SEE REMARKS | 12/08/2022 | 21,400 |
| Dake Benjamin T | SEE REMARKS | 12/09/2022 | 9,861 |
| Dake Benjamin T | SEE REMARKS | 12/08/2022 | 226,449 |
| Eldridge George A | SEE REMARKS | 12/08/2022 | 25,704 |
| Eldridge George A | SEE REMARKS | 12/07/2022 | 24,903 |
| Eldridge George A | SEE REMARKS | 12/08/2022 | 286,700 |
| Eldridge George A | SEE REMARKS | 12/07/2022 | 230,083 |
| Dake Benjamin T | SEE REMARKS | 12/06/2022 | 84,635 |
| Dake Benjamin T | SEE REMARKS | 12/06/2022 | 706,772 |
| NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | 12/05/2022 | 4,555 |
| NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | 12/05/2022 | 39,114 |
| NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | 12/01/2022 | 32,100 |
| NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | 12/01/2022 | 270,000 |
| Eldridge George A | SEE REMARKS | 11/30/2022 | 182 |
| Eldridge George A | SEE REMARKS | 11/30/2022 | 1,620 |
| Eldridge George A | SEE REMARKS | 11/23/2022 | 2,699 |
| Eldridge George A | SEE REMARKS | 11/23/2022 | 24,048 |
| Eldridge George A | SEE REMARKS | 11/22/2022 | 372 |
| Eldridge George A | SEE REMARKS | 11/21/2022 | 4 |
| Eldridge George A | SEE REMARKS | 11/18/2022 | 1,843 |
| Eldridge George A | SEE REMARKS | 11/22/2022 | 3,308 |
| Eldridge George A | SEE REMARKS | 11/21/2022 | 38 |
| Eldridge George A | SEE REMARKS | 11/18/2022 | 16,805 |
| Dake Benjamin T | SEE REMARKS | 11/11/2022 | 13,264 |
| Dake Benjamin T | SEE REMARKS | 11/10/2022 | 3,852 |
| Dake Benjamin T | SEE REMARKS | 11/09/2022 | 29,960 |
| Dake Benjamin T | SEE REMARKS | 11/11/2022 | 128,236 |
| Dake Benjamin T | SEE REMARKS | 11/10/2022 | 36,172 |
| Dake Benjamin T | SEE REMARKS | 11/09/2022 | 250,677 |
| Dake Benjamin T | SEE REMARKS | 11/08/2022 | 17,918 |
| Dake Benjamin T | SEE REMARKS | 11/07/2022 | 36,757 |
| Dake Benjamin T | SEE REMARKS | 11/08/2022 | 151,458 |
| Dake Benjamin T | SEE REMARKS | 11/07/2022 | 322,894 |
| NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | 11/07/2022 | 4,555 |
| NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | 11/07/2022 | 43,194 |
| NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | 11/01/2022 | 20,241 |
| Verwijs Marinus | SENIOR VICE PRESIDENT, CMC | 11/02/2022 | 21,346 |
| Dake Benjamin T | SEE REMARKS | 10/18/2022 | 12,209 |
| Dake Benjamin T | SEE REMARKS | 10/18/2022 | 120,287 |
| Dake Benjamin T | SEE REMARKS | 10/14/2022 | 235 |
| Dake Benjamin T | SEE REMARKS | 10/17/2022 | 8,956 |
| Dake Benjamin T | SEE REMARKS | 10/17/2022 | 84,380 |
| Dake Benjamin T | SEE REMARKS | 10/14/2022 | 2,205 |
| Dake Benjamin T | SEE REMARKS | 10/10/2022 | 10,602 |
| Dake Benjamin T | SEE REMARKS | 10/10/2022 | 83,681 |
| Dake Benjamin T | SEE REMARKS | 10/06/2022 | 26,941 |
| Dake Benjamin T | SEE REMARKS | 10/07/2022 | 22,513 |
| Dake Benjamin T | SEE REMARKS | 10/07/2022 | 168,460 |
| Dake Benjamin T | SEE REMARKS | 10/06/2022 | 206,344 |
| NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | 10/05/2022 | 4,555 |
| NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | 10/05/2022 | 35,447 |
| Dake Benjamin T | SEE REMARKS | 09/12/2022 | 16,093 |
| Dake Benjamin T | SEE REMARKS | 09/12/2022 | 130,307 |
| Dake Benjamin T | See Remarks | 09/08/2022 | 5,429 |
| Dake Benjamin T | See Remarks | 09/09/2022 | 9,998 |
| Dake Benjamin T | See Remarks | 09/08/2022 | 56,782 |
| Dake Benjamin T | See Remarks | 09/09/2022 | 82,803 |
| Dake Benjamin T | See Remarks | 09/07/2022 | 14,303 |
| Dake Benjamin T | See Remarks | 09/06/2022 | 15,949 |
| Dake Benjamin T | See Remarks | 09/07/2022 | 67,477 |
| Dake Benjamin T | See Remarks | 09/06/2022 | 169,876 |
| NIVEN RALPH | Chief Scientific Officer | 09/06/2022 | 4,555 |
| NIVEN RALPH | Chief Scientific Officer | 09/06/2022 | 42,750 |
| NIVEN RALPH | Chief Scientific Officer | 08/18/2022 | 4,555 |
| NIVEN RALPH | Chief Scientific Officer | 08/18/2022 | 47,657 |
| Dake Benjamin T | See Remarks | 08/16/2022 | 36,540 |
| Dake Benjamin T | See Remarks | 08/16/2022 | 482,932 |
| Dake Benjamin T | See Remarks | 08/11/2022 | 2,344 |
| Dake Benjamin T | See Remarks | 08/10/2022 | 22,133 |
| Dake Benjamin T | See Remarks | 08/11/2022 | 32,232 |
| Dake Benjamin T | See Remarks | 08/10/2022 | 306,366 |
| Dake Benjamin T | See Remarks | 08/08/2022 | 12,081 |
| Dake Benjamin T | See Remarks | 08/09/2022 | 15,138 |
| Dake Benjamin T | See Remarks | 08/09/2022 | 209,325 |
| Dake Benjamin T | See Remarks | 08/08/2022 | 170,962 |
| Cormorant Asset Management, LP | Former 10% Owner | 07/02/2021 | 7,000,000 |
| RA CAPITAL MANAGEMENT, L.P. | Director | 07/02/2021 | 38,999,996 |
| Sofinnova Venture Partners X, L.P. | 10% Owner | 07/02/2021 | 4,999,988 |
| Katabi Maha | Director | 07/02/2021 | 4,999,988 |
| GRAYZEL DAVID S. | Director | 07/02/2021 | 7,499,996 |
| Atlas Venture Fund XII, L.P. | 10% Owner | 07/02/2021 | 7,499,996 |
Load More Insider Transactions
FUNDS WITH A POSITION IN AEROVATE THERAPEUTICS INC
| Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 8,263,982 | 2.68% | No change | Other |
| BAKER BROS. ADVISORS LP | 1,963,479 | 0.19% | No change | Other |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 1,194,091 | 0.26% | New | Growth |
| ORBIMED ADVISORS LLC | 756,930 | 0.24% | No change | Other |
| BLACKROCK INC. | 622,647 | 0.00029% | 3.77% | Other |
| GEODE CAPITAL MANAGEMENT, LLC | 203,058 | 0.00041% | 8.3% | Other |
| ALPS ADVISORS INC | 18,320 | 0.00273% | 13.03% | Other |
CHANGE IN SHARES OUTSTANDING FOR AEROVATE THERAPEUTICS INC
STOCK BUYBACKS FOR AEROVATE THERAPEUTICS INC
Load More
Period of Report: 06/30/2023
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
03/31/2023
1.57%
1Q
12/31/2022
2.25%
2Q
09/30/2022
2.91%
3Q
06/30/2022
3.10%
4Q
03/31/2022
3.10%
5Q
09/30/2021
5.37%
7Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR AEROVATE THERAPEUTICS INC
LOADING...